Clear Search

Showing 1 result for “Armstrong A”.

October 2022

乾癬性関節炎におけるグセルクマブの比較検討: 文献検索とメタ解析のアップデート

Rheumatology (Oxford). 2022 doi: 10.1093/rheumatology/keac500

Guselkumab (GUS) demonstrates better skin efficacy than most other targeted PsA therapies, including upadacitinib. The objective of this NMA update was to expand the network to include all targeted therapies in PsA on arthritis, skin efficacy and safety, and to include data on GUS patients with an IR to TNFinibs.